<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55002997"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<reference>ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1979, p. 329-332<lb/> Vol. 16, No. 3<lb/></reference>

	<note type="other">0066-4804/79/09-0329/04$02.00/0<lb/></note>

	<docTitle>
	<titlePart>Na-Cocoyl-L-Arginine Ethyl Ester, DL-Pyroglutamic Acid Salt,<lb/> As an Inactivator of Hepatitis B Surface Antigen<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>YOSHIKAZU SUGIMOTO* AND SHIGESHI TOYOSHIMA<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>Division of Chemotherapy, Pharmaceutical Institute, School ofMedicine, Keio University, Shinjuku-ku,<lb/></affiliation>
	</byline>

	<address>Tokyo 160, Japan<lb/></address>

	<note type="submission">Received for publication 26 June 1979<lb/></note>

	<div type="abstract">Na-Cocoyl-L-arginine ethyl ester, DL-pyroglutamic acid salt (CAE), exhibited a<lb/> strong inactivating effect on hepatitis B surface antigen. Concentrations of CAE<lb/> required for 50 and 100% inactivation of the antigen were 0.01 to 0.025% and 0.025<lb/> to 0.05%, respectively.</div>

		</front>
	</text>
</tei>
